β-连环蛋白在软组织肿瘤中的研究进展

doi:10.11904/j.issn.1002-3070.2018.05.014

摘要/Abstract

摘要： β-连环蛋白(β-catenin)作为一种胞浆蛋白及转录蛋白在肿瘤的发生发展中起双重作用。近年来,β-catenin及其相关Wnt/β-catenin信号通路在肿瘤中的异常调节受到越来越多的关注。软组织肉瘤好发于四肢及躯干,在中青年人群中发病率较高,其分类复杂,进展期恶性程度较高,亟待靶向药物缓解病程进展。本文就β-catenin在软组织肉瘤中的表达模式及其在增殖、转移、凋亡、分化、自我更新方面的相关作用机制进行全面概括,以期改善患者的临床预后,为软组织肿瘤的靶向治疗带来新希望。

关键词: β-连环蛋白, 软组织肉瘤, 作用机制, 靶向治疗

Abstract: As a cytoplasmic protein and transcriptional protein,β-catenin plays a dual role in the occurrence and development of tumors.In recent years,the abnormal regulation of β-catenin and its related Wnt/β-catenin signaling pathway in tumors have attracted more and more scholars' attention.Soft tissue sarcoma occurs in the limbs and trunks,especially in young and middle-aged people.The classification of soft tissue sarcoma is complicated,and the degree of malignancy is high in advanced phase.It is urgent to target drugs to alleviate the progress of this disease.In this paper,the expression pattern of β-catenin in soft tissue tumors and its related mechanisms involved in the proliferation,metastasis,apoptosis,differentiation and self-renewal of soft tissue sarcomas are comprehensively summarized in order to improve the clinical prognosis of patients and bring new hope for targeted therapy.

Key words: β-catenin, Soft tissue tumor, Mechanism of action, Targeted treatment

中图分类号:

R738.6

王元综述, 孙轶华审校. β-连环蛋白在软组织肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(5): 455-459.

WANG Yuan, SUN Yihua. Advance in the role of β-catenin in soft tissue tumors[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 455-459.

参考文献

1 Jo VY,Doyle LA.Refinements in sarcoma classification in the current 2013 World Health Organization classification of tumours of soft tissue and bone[J].Surg Oncol Clin N Am,2016,25(4):621-643.
2 Tan MTL,Thompson SR,Schipp D,et al.Patterns of care of superficial soft tissue sarcomas:it is not always just a lump[J].Asia Pac J Clin Oncol,2018[Epub ahead of print].
3 Bandino A,Compagnone A,Bravoco V,et al.β-catenin triggers nuclear factor κB-dependent up-regulation of hepatocyte inducible nitric oxide synthase[J].Int J Biochem Cell B,2008,40(9):1861-1871.
4 Martinez-Font E,Felipe-Abrio I,Calabuig-Fariñas S,et al.Disruption of TCF/β-catenin binding impairs Wnt signalling and induces apoptosis in soft tissue sarcoma cells[J].Mol Cancer Ther,2017,16(6):1166-1176.
5 王翠翠,张薇,刘春霞,等.滑膜肉瘤中E-、N-cadherin和β-catenin的表达及意义[J].临床与实验病理学杂志,2012,28(8):874-879.
6 Indersie E,Lesjean S,Hooks KB,et al.MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β-catenin and Wnt signaling[J].Hepatol Commun,2017,1(2):168-183.
7 Ng TL,Gown AM,Barry TS,et al.Nuclear beta-catenin in mesenchymal tumors[J].Mod Pathol,2005,18(1):68-74.
8 Saito T,Oda Y,Sakamoto A,et al.Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of beta-catenin mutations in synovial sarcoma[J].J Pathol,2000,192(3):342-350.
9 Bouron-Dal Soglio D,Rougemont AL,Absi R,et al.Beta-catenin mutation does not seem to have an effect on the tumorigenesis of pediatric rhabdomyosarcomas[J].Pediatr Dev Pathol,2009,12(5):371-373.
10 Aggarwal A,Prinz-Wohlgenannt M,Grñschel C,et al.The calcium-sensing receptor suppresses epithelial-to-mesenchymal transition and stem cell-like phenotype in the colon[J]Mol Cancer,2015,14:61.
11 Zheng L,Liu Y,Pan J.Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt/β-catenin pathway[J].Acta Biochim Biophys Sin(Shanghai),2017,49(10):890-898.
12 Annavarapu SR,Cialfi S,Dominici C,et al.Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma[J].Lab Invest,2013,93(10):1090-1099.
13 Cowan ML,Thompson LD,Leon ME,et al.Low-grade fibromyxoid sarcoma of the head and neck:a clinicopathologic series and review of the literature[J].Head Neck Pathol,2016,10(2):161-166.
14 Rooper LM,Huang SC,Antonescu CR,et al.Biphenotypic sinonasal sarcoma:an expanded immunoprofile including consistent nuclear β-catenin positivity and absence of SOX10 expression[J].Hum Pathol,2016,55:44-50.
15 Qi Y,Wang CC,He YL,et al.The correlation between morphology and the expression of TGF-β signaling pathway proteins and epithelial-mesenchymal transition-related proteins in synovial sarcomas[J].Int J Clin Exp Pathol,2013,6(12):2787-2799.
16 Yang J,Du X,Wang G,et al.Mesenchymal to epithelial transition in sarcomas[J].Eur J Cancer,2014,50(3):593-601.
17 Zhang P,Bill K,Liu J,et al.MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling[J].Cancer Res,2012,72(7):1751-1762.
18 Sakamoto A,Oda Y,Adachi T,et al.β-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma.[J].Arch Pathol Lab Med,2002,126(9):1071-1078.
19 Gogou P,Pakos E,Batistatou A,et al.Clinicopathologic study of E-cadherin/beta-catenin complex,and topoisomerase-II in a series of 71 liposarcoma cases.[J].World J Surg Oncol,2012,10:28.
20 Weiss S,Goldglum J.Enzinger and Weiss's soft tissue tumors[M].4th ed.Philadelphia:Mosby,2001.
21 Honoki K,Fujii H,Tohma Y,et al.Comparison of gene expression profiling in sarcomas and mesenchymal stem cells identifies tumorigenic pathways in chemically induced rat sarcoma model.[J].ISRN Oncol,2012,2012:909453.
22 Kouvidi K,Berdiaki A,Tzardi M,et al.Receptor for hyaluronic acid-mediated motility(RHAMM)regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis[J].Biochim Biophys Acta,2016,1860(4):814-824.
23 Barrott JJ,Illum BE,Jin H,et al.β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition[J].Oncotarget,2015,6(26):22758-22766.
24 Tang J,Shi H,Li H,et al.The interaction of hepatoma-derived growth factor and β-catenin promotes tumorigenesis of synovial sarcoma[J].Tumour Biol,2016,37(8):10287-10301.
25 Pedersen EA,Menon R,Bailey KM,et al.Activation of Wnt/β-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states[J].Cancer Res,2016,76(17):5040-5053.
26 Hawkins AG,Basrur V,da Veiga Leprevost F,et al.The Ewing sarcoma secretome and its response to activation of Wnt/beta-catenin signaling[J].Mol Cell Proteomics,2018,17(5):901-912.
27 Singh S,Vinson C,Gurley CM,et al.Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice[J].Am J Pathol,2010,177(4):2055-2066.
28 Trautmann M,Sievers E,Aretz S,et al.SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma[J].Oncogene,2014,33(42):5006-5016.
29 Dräger J,Simon-Keller K,Pukrop T,et al.LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma[J].Oncotarget,2017,8(2):3259-3273.
30 Chen EY,DeRan MT,Ignatius MS,et al.Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma[J].Proc Natl Acad Sci U S A,2014,111(14):5349-5354.
31 Kephart JJ,Tiller RG,Crose LE,et al.Secreted frizzled-related protein 3(SFRP3)is required for tumorigenesis of PAX3-FOXO1-positive alveolar rhabdomyosarcoma[J].Clin Cancer Res,2015,21(21):4868-4880.
32 Villar VH,Vögler O,Barceló F,et al.Down-regulation of AKT signalling by ursolic acid induces intrinsic apoptosis and sensitization to doxorubicin in soft tissue sarcoma.[J].PLoS One,2016,11(5):e0155946.
33 Cironi L,Petricevic T,Fernandes Vieira V,et al.The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma[J].Sci Rep,2016,6:22113.
34 Barham W,Frump AL,Sherrill TP,et al.Targeting the wnt pathway in synovial sarcoma models[J].Cancer Discov,2013,3(11):1286-1301.

[1]	朱琳,张春霞. 纳米载药系统靶向肿瘤干细胞的研究进展[J]. 实用肿瘤学杂志, 2019, 33(3): 276-279.
[2]	李悦, 徐可, 韩增祥, 孙敏, 樊国华综述, 张勇审校. 结肠癌中肿瘤相关巨噬细胞的作用及靶向治疗的研究进展[J]. 实用肿瘤学杂志, 2018, 32(5): 450-454.
[3]	张婷, 贾迪(综述), 杨丹(审校). 骨肉瘤的生物学治疗进展[J]. 实用肿瘤学杂志, 2018, 32(3): 254-257.
[4]	黄倩倩, 马建加, 吴强, 刘彬彬, 沐晓芹, 刘树林审校. 肿瘤干细胞及肿瘤靶向治疗的研究进展[J]. 实用肿瘤学杂志, 2017, 31(6): 533-537.
[5]	黄承路, 韩少辉徐苏琴综述, 赵俊刚审校. 原发性肺黏液腺癌的研究进展[J]. 实用肿瘤学杂志, 2017, 31(5): 463-467.
[6]	孙禹琪,陈秀玮. CTGF/CCN2在恶性肿瘤的发生发展及靶向治疗中的研究进展[J]. 实用肿瘤学杂志, 2017, 31(4): 363-366.
[7]	侯阳明, 徐颖娟综述, 崔云甫审校. 干扰素调节因子-4结合蛋白与癌症的相关研究进展[J]. 实用肿瘤学杂志, 2017, 31(1): 93-96.
[8]	左志超, 苏丹柯, 邓文娟综述, 金观桥审校. ELAM-1在肿瘤靶向治疗中的应用进展[J]. 实用肿瘤学杂志, 2016, 30(5): 444-447.
[9]	赵相轩, 温锋, 毛晓楠综述, 卢再鸣审校. 细胞凋亡在原发性肝癌治疗中的作用研究进展[J]. 实用肿瘤学杂志, 2016, 30(5): 448-452.
[10]	赵相轩,温锋综述,卢再鸣审校. 细胞凋亡在胰腺癌治疗中的作用[J]. 实用肿瘤学杂志, 2016, 30(4): 375-379.
[11]	刘伟综述, 李惠艳审校. 表皮生长因子受体与放射敏感性关系的研究进展[J]. 实用肿瘤学杂志, 2016, 30(3): 275-278.
[12]	潘夏综述, 江建平审校. Alectinib在非小细胞肺癌治疗中的研究进展[J]. 实用肿瘤学杂志, 2016, 30(1): 75-79.
[13]	吕福莲, 高翔综述, 金艾顺审校. 肿瘤干细胞潜在标志物DCLK1在消化道恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2015, 29(5): 458-461.
[14]	黄东宁¹, 梁小娜²综述, 陈罡²审校. 长链非编码RNA在结直肠癌中的研究进展[J]. 实用肿瘤学杂志, 2015, 29(3): 263-266.
[15]	张佳文, 曹京燕, 金时综述, 于雁审校. Hsp90抑制剂NVP-AUY922单药及联合用药在肿瘤治疗中的研究进展[J]. 实用肿瘤学杂志, 2015, 29(3): 284-288.